Ian Frazer is a Scottish-born Australian immunologist and the founding CEO and Director of Research of the Translational Research Institute.

Frazer and Jian Zhou developed and patented the basic technology behind the HPV vaccine against cervical cancer at the University of Queensland. The vaccine, now marketed as Gardasil and Cervarix, was the second cancer preventing vaccine, and the first vaccine designed to prevent a cancer.

In 2006, results from the four-year Phase III trials led to Australian and US regulatory approval. Frazer's studies showed 100% efficacious protective immunity in HPV naïve women, but could not directly test protective immunity (against HPV exposure) in adolescent girls. As a surrogate test, antibody titer levels in vaccinated 9 to 15-year-old girls was shown high enough to give them the same level of immunity as vaccinated women.

Frazer administered the first official HPV-vaccination and was made 2006 Queenslander of the Year and Australian of the Year.

Frazer lives in Brisbane, Australia with his wife Caroline. Two of his sons are medical students and the third is a veterinary scientist.

Health, Cancer, Vaccines, Physician, Pharmaceutical, Healthcare, Immunology, Gene Therapy, Medicine, Science, Epidemics & Pandemics